If anyone's interested in reading about EMIR, the Regulation on OTC Derivatives, Central Counterparties and Trade Repositories that came into force in August 2012, the briefing that's available for download at the bottom of the following website might be useful: http://www.linklaters.com/Publications/Publication1005Newsletter/UK-Corporate-Update-6-Sept-2012/Pages/New-EU-Regulation-derivatives-corporates-need-know.aspx I'd be interested to hear what you think about this regulation and how it's affecting your companies.
